The ABPI has today launched a clinical trial disclosure toolkit to help pharmaceutical companies meet clinical trial transparency requirements.
The toolkit is comprised of 11 elements, including good practice guidelines, disclosure checklists and template standard operating procedure. These documents are intended as an additional support to guide companies of all sizes through the different steps of the disclosure process. Commenting on the launch of the toolkit, ABPI Chief Executive Stephen Whitehead said:
"The ABPI is a strong advocate for transparency in clinical trial information. Earlier this year we committed to providing a clinical trial disclosure toolkit to companies and I am delighted that this is now available on our website for any company to use. The pharmaceutical industry has been, and continues to be, committed to addressing the issues relating to transparency in clinical research. "Research is a truly global activity, with the UK supplying less than 2% of patients to global clinical trials. As part of a global industry, we are actively engaging with our European and international counterparts, as well as many other stakeholders, to input into ongoing discussions around clinical trial transparency."
The toolkit is available to download from the ABPI website.
ABPI Press OfficeTel: +44 (0) 20 7747 1441Mobile: +44 (0) 7808 641811 Email: [email protected]